Discover
BGMS
Bio Green Med Solution, Inc.
0.85
2 x 0.61
2 x 1.17
bid
ask
+
0.03
3.41%
2 @ 07:59 PM
0.67 -0.18 (20.94%)
| Ytd | -42.64% | |
| 1y | -83.58% |
0.80
day range
0.85
0.60
52 week range
5.95
| Open | 0.80 | Prev Close | 0.82 | Low | 0.80 | High | 0.85 | Mkt Cap | 5.62M |
| Vol | 23.85K | Avg Vol | 74.12K | EPS | -5.02 | P/E | N/A | Forward P/E | N/A |
| Beta | -0.39 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.90 | 200-d Avg | 1.01 | 1yr Est | 0.00 |
| Income Statement | |||
| Total Revenue | 336.00K | ||
| Revenues (USD) | 336.00K | ||
| Cost of Revenue | 257.00K | ||
| Gross Profit | 79.00K | ||
| Operating Expenses | 497.00K | ||
| Selling, General and Administrative Expense | 497.00K | ||
| Operating Income | -418.00K | ||
| Interest Expense | -9.00K | ||
| Income Tax Expense | 9.00K | ||
| Net Income | -405.00K | ||
| Net Income Common Stock | -425.00K | ||
| Net Income Common Stock (USD) | -425.00K | ||
| Consolidated Income | -405.00K | ||
| Earnings per Basic Share | -0.08 | ||
| Earnings per Basic Share (USD) | -0.08 | ||
| Earnings per Diluted Share | -0.08 | ||
| Earning Before Interest & Taxes (EBIT) | -405.00K | ||
| Earning Before Interest & Taxes (USD) | -405.00K | ||
| Preferred Dividends Income Statement Impact | 20.00K | ||
| Weighted Average Shares | 5.60M | ||
| Weighted Average Shares Diluted | 5.60M | ||
| Balance Sheet | |||
| Cash and Equivalents | 3.79M | ||
| Cash and Equivalents (USD) | 3.79M | ||
| Trade and Non-Trade Receivables | 1.07M | ||
| Current Assets | 5.97M | ||
| Property, Plant & Equipment Net | 143.00K | ||
| Total Assets | 7.85M | ||
| Current Liabilities | 692.00K | ||
| Total Liabilities | 694.00K | ||
| Accumulated Retained Earnings (Deficit) | -455.01M | ||
| Shareholders Equity | 7.16M | ||
| Shareholders Equity (USD) | 7.16M | ||
| Assets Non-Current | 1.89M | ||
| Goodwill and Intangible Assets | 1.57M | ||
| Inventory | 972.00K | ||
| Liabilities Non-Current | 2.00K | ||
| Trade and Non-Trade Payables | 189.00K | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 773.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 451.00K | ||
| Issuance (Purchase) of Equity Shares | 794.00K | ||
| Net Cash Flow from Operations | -352.00K | ||
| Effect of Exchange Rate Changes on Cash | 30.00K | ||